高鴻股份(000851.SZ):擬定增募資不超12.5億元 控股股東認購不低於1.6億元
格隆匯8月24日丨高鴻股份(000851.SZ)披露2020年度非公開發行股票預案,發行對象為包括公司控股股東電信科研院在內的不超35名特定對象。其中,電信科研院承諾認購金額不低於1.6億元。
發行價格不低於發行期首日前20個交易日公司股票交易均價的80%;發行數量不超2.64億股,電信科研院鎖定期18個月,其他認購對象鎖定期6個月;募資總額不超12.5億元,其中10億元擬投向車聯網系列產品研發及產業化項目,2.5億元擬用於償還銀行借款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.